Issuer · CIK 0001672619
ELVN — Enliven Therapeutics, Inc.
Recent filings
- Jun 17, 2026·Form 4·Sell$12.3M
ELVN/Enliven Therapeutics, Inc.
ORBIMED ADVISORS LLC · 10pct_owner
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Sell$266.7K
ELVN/Enliven Therapeutics, Inc.
Kunkel Lori Anne · director
Mechanical filing
AI thesis skipped - May 20, 2026·Form 4·Sell$137.4K
ELVN/Enliven Therapeutics, Inc.
Collins Helen Louise · director
Mechanical filing
AI thesis skipped - Feb 17, 2026·Form 4·Other—
ELVN/Enliven Therapeutics, Inc.
Heyman Richard A. · director
Mechanical filing
AI thesis skipped